Edition:
India

Biocryst Reports Q4 Loss Per Share of $0.20


Tuesday, 27 Feb 2018 

Feb 27 (Reuters) - Biocryst Pharmaceuticals Inc ::BIOCRYST REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS.Q4 LOSS PER SHARE $0.20.Q4 REVENUE $3.9 MILLION VERSUS $9.0 MILLION.CASH, CASH EQUIVALENTS & INVESTMENTS TOTALED $159.0 MILLION AT DEC 31, 2017, REFLECTS INCREASE FROM $65.1 MILLION AT DEC 31, 2016.EXPECTS ITS 2018 NET OPERATING CASH USE TO BE IN RANGE OF $67 TO $90 MILLION.SEES 2018 OPERATING EXPENSES TO BE IN RANGE OF $85 TO $110 MILLION. 

Company Quote

2.5
0.11 +4.60%
1:30am IST